Abramson Cancer Center:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Abramson Cancer Center - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C9319
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:22
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Abramson Cancer Center (Abramson) formerly Penn Medicine’s Cancer Center, a subsidiary of University of Pennsylvania is a healthcare service center that provides clinical trials for the prevention, diagnosis and treatment of cancer. The center provides supportive care services, which include integrative medicine and wellness, nutritional counseling, pastoral care, patient education and psychological counselling. It offers cancer treatments such as bone marrow and stem cell transplantation, chemotherapy, clinical trials, hormone therapy, immunotherapy, integrative medicine and wellness, managing treatment side effects, photodynamic therapy, proton therapy, radiation treatment, surgery, targeted therapy,vaccine therapy. Abramson treats for bladder cancer, breast cancer, kidney cancer, lung cancer, ovarian cancer, thyroid cancer, among others. The centre pathologists perform specialized techniques including immunohistochemical analyses, electron microscopy and molecular studies. Its centre offers services in various hospital locations across the US. Abramson Cancer Center is headquartered in Philadelphia, Pennsylvania, the US.

Abramson Cancer Center – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Abramson Cancer Center, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Abramson Cancer Center, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Abramson Cancer Center, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Abramson Cancer Center, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Abramson Cancer Center, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Abramson Cancer Center, Pharmaceuticals & Healthcare, Deal Details 10
Partnerships 10
Incyte Enters into Research Agreement with Abramson Cancer Center 10
Celgene Enters into Co-Development Agreement with Abramson Cancer Center 11
Epic Sciences Partners with Abramson Cancer Center 12
Abramson Cancer Center – Key Competitors 13
Abramson Cancer Center – Key Employees 14
Abramson Cancer Center – Locations And Subsidiaries 15
Head Office 15
Other Locations & Subsidiaries 15
Recent Developments 16
Government and Public Interest 16
Oct 03, 2018: Patient death following CAR-T therapy highlights serious manufacturing issues 16
Sep 07, 2018: Penn Medicine Researchers Receive “Big Data” Grant from NIH to Test New Approach for Personalized Breast Cancer Treatments 18
Nov 01, 2017: CVS Health Foundation Awards $1 Million Dollars in Grants to Eight Cancer Centers to Increase Smoking Cessation Resources in the Oncology Setting 19
May 04, 2017: New $21 Million Gift Puts Basser Center for BRCA at the Forefront of Advancements for Patients at Risk of Inherited Cancers 20
Appendix 22
Methodology 22
About GlobalData 22
Contact Us 22
Disclaimer 22

List of Tables
Abramson Cancer Center, Pharmaceuticals & Healthcare, Key Facts 2
Abramson Cancer Center, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Abramson Cancer Center, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Abramson Cancer Center, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Abramson Cancer Center, Deals By Therapy Area, 2012 to YTD 2018 8
Abramson Cancer Center, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Incyte Enters into Research Agreement with Abramson Cancer Center 10
Celgene Enters into Co-Development Agreement with Abramson Cancer Center 11
Epic Sciences Partners with Abramson Cancer Center 12
Abramson Cancer Center, Key Competitors 13
Abramson Cancer Center, Key Employees 14
Abramson Cancer Center, Other Locations 15

List of Figures
Abramson Cancer Center, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Abramson Cancer Center, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Abramson Cancer Center, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Abramson Cancer Center, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Abramson Cancer Center, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Abramson Cancer Center, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Abramson Cancer Center, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Abramson Cancer Center, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[Abramson Cancer Center:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Singapore Petroleum Co Ltd:企業の戦略的SWOT分析
    Singapore Petroleum Co Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • Goldcorp Inc:企業の戦略・SWOT・財務情報
    Goldcorp Inc - Strategy, SWOT and Corporate Finance Report Summary Goldcorp Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • Arrow Electronics Inc (ARW):企業の財務・戦略的SWOT分析
    Arrow Electronics Inc (ARW) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • Paradise Co Ltd
    Paradise Co Ltd - Strategy, SWOT and Corporate Finance Report Summary Paradise Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Immune Pharmaceuticals Inc (IMNP):企業の財務・戦略的SWOT分析
    Summary Immune Pharmaceuticals Inc (Immune Pharma), formerly EpiCept Corp is a drug development company that develops novel therapies for immunologic and inflammatory diseases. The company’s pipeline products include Bertilimumab and Nanocyclo. Its Bertilimumab is a human monoclonal antibody designe …
  • Sihuan Pharmaceutical Holdings Group Ltd (460):企業の財務・戦略的SWOT分析
    Summary Sihuan Pharmaceutical Holdings Group Ltd (Sihuan Pharmaceutical) is a pharmaceutical company that develops, manufactures and markets prescription drugs. The company offers products in the therapeutic areas of cardio-cerebral vascular system, central nervous system, metabolism, oncology and a …
  • Gray Television, Inc. (GTN):企業の財務・戦略的SWOT分析
    Gray Television, Inc. (GTN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • Wolters Kluwer nv:企業の戦略・SWOT・財務情報
    Wolters Kluwer nv - Strategy, SWOT and Corporate Finance Report Summary Wolters Kluwer nv - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Israel Corporation Limited:企業のM&A・事業提携・投資動向
    Israel Corporation Limited - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Israel Corporation Limited Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acqui …
  • Cummins Inc (CMI):電力:M&Aディール及び事業提携情報
    Summary Cummins Inc. (Cummins), formerly Cummins Engine Company, is a manufacturer of diesel engines and related technologies. It designs, manufactures, services and distributes engines and related component solutions. The company offers filtration, fuel systems, control systems, after treatment dev …
  • Grohe AG:企業の戦略的SWOT分析
    Grohe AG - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. Thi …
  • First Gen Corp (FGEN):企業の財務・戦略的SWOT分析
    First Gen Corp (FGEN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Mirvac Group:企業のM&A・事業提携・投資動向
    Mirvac Group - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Mirvac Group Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, …
  • Adgero Biopharmaceuticals Holdings Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Adgero Biopharmaceuticals Holdings Inc (Adgero), formerly Adgero Biopharmaceuticals Inc is a biopharmaceutical company that develops proprietary late stage photodynamic therapy platform for the treatment of oncology indications. The company’s pipeline products include REM-001. Its product is …
  • Pegasi Energy Resources Corp:石油・ガス:M&Aディール及び事業提携情報
    Summary Pegasi Energy Resources Corp (PERC) is an energy company that explores, produces, and develops oil and natural gas from its properties. The company produces natural gas and oil through the development of a low geological, repeatable, and high potential project in the Rodessa East Texas oil a …
  • Iberdrola Ingenieria y Construccion SAU:企業の戦略・SWOT・財務情報
    Iberdrola Ingenieria y Construccion SAU - Strategy, SWOT and Corporate Finance Report Summary Iberdrola Ingenieria y Construccion SAU - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT a …
  • Active Biotech AB (ACTI):企業の財務・戦略的SWOT分析
    Active Biotech AB (ACTI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Meridian Energy Ltd (MEL):企業の財務・戦略的SWOT分析
    Meridian Energy Ltd (MEL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Auswide Bank Ltd (ABA):企業の財務・戦略的SWOT分析
    Auswide Bank Ltd (ABA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • Intellia Therapeutics Inc (NTLA):企業の財務・戦略的SWOT分析
    Summary Intellia Therapeutics Inc (Intellia Therapeutics) is a genome editing company. It develops proprietary curative therapeutics using CRISPR/Cas9 technology. The company develops in vivo programs for the treatment of liver diseases such as alpha-1 antitrypsin deficiency, and primary hyperoxalur …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆